ArticleMolecules (Basel, Switzerland)2025
Towards Spectral Variation Analysis: A Data Quality Framework for Non-Targeted Methods.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-targeted methods (NTMs) require robust methods for comparing spectral data for reliable classification and identification. Traditional approaches using match factors reduce complex spectral relationships to single values, limiting their utility in quality assurance. This study presents an evaluation of spectral comparison methodologies, contrasting classical Mahalanobis distance (MD) with neural network approaches, namely, neural classification distance (NCD). Using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry data from bacterial isolates, we systematically assessed these methods across varying levels of spectral variability. The MD approach exhibited consistent performance under controlled conditions but showed limitations with increasing spectral complexity. In contrast, the NCD demonstrated adaptability across all scenarios, revealing its capability in handling complex spectral relationships. Through this exemplary example, we present the mathematical framework for quantifying spectral variations and establish criteria for method selection in different analytical scenarios. This work provides a foundation for proposing data quality metrics in NTMs and offers practical implementations for routine quality assurance. The methodology developed here extends beyond mass spectrometry applications and contributes to the broader field of analytical quality control in complex spectral analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.